Managed Account Advisors’s Invesco Biotechnology & Genome ETF PBE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2015
Q2 | $904K | Buy |
15,492
+1,110
| +8% | +$64.8K | ﹤0.01% | 2137 |
|
|
2015
Q1 | $793K | Buy |
14,382
+2,463
| +21% | +$136K | ﹤0.01% | 2157 |
|
|
2014
Q4 | $598K | Buy |
11,919
+1,660
| +16% | +$83.3K | ﹤0.01% | 2169 |
|
|
2014
Q3 | $474K | Sell |
10,259
-272
| -3% | -$12.6K | ﹤0.01% | 2187 |
|
|
2014
Q2 | $460K | Buy |
10,531
+4,006
| +61% | +$175K | ﹤0.01% | 2173 |
|
|
2014
Q1 | $272K | Buy |
6,525
+1,659
| +34% | +$69.2K | ﹤0.01% | 2200 |
|
|
2013
Q4 | $180K | Buy |
4,866
+444
| +10% | +$16.4K | ﹤0.01% | 2226 |
|
|
2013
Q3 | $155K | Buy |
4,422
+1,714
| +63% | +$60.1K | ﹤0.01% | 2176 |
|
|
2013
Q2 | $78K | Buy |
+2,708
| New | +$78K | ﹤0.01% | 2241 |
|